Clinical Trials Logo

Clinical Trial Summary

A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Placebo in the Treatment of Adenoviral Conjunctivitis


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03749317
Study type Interventional
Source IVIEW Therapeutics Inc.
Contact
Status Completed
Phase Phase 2
Start date December 19, 2019
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT01532336 - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Phase 2
Terminated NCT02998554 - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo Phase 3
Terminated NCT02998541 - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Phase 3
Completed NCT02472223 - Reducing Adenoviral Patient Infected Days N/A
Terminated NCT00901693 - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis Phase 2
Withdrawn NCT03009799 - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Phase 2
Active, not recruiting NCT03856645 - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis Phase 2
Completed NCT00266734 - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears N/A